UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 146

Sortiert nach

Symptoms of Autonomic Dysfunction in Systemic Sclerosis Assessed by the COMPASS-31 Questionnaire

Journal of rheumatology, 2018-08, Vol.45 (8), p.1145

2018

Link zum Volltext

Verfügbarkeit prüfen

Gastrointestinal involvement in systemic sclerosis: diagnosis and management

Current opinion in rheumatology, 2018-11, Vol.30 (6), p.533-540

2018

Link zum Volltext

Verfügbarkeit prüfen

Right Ventricular Functional Reserve in Pulmonary Arterial Hypertension

Circulation (New York, N.Y.), 2016-06, Vol.133 (24), p.2413-2422

2016

Link zum Volltext

Verfügbarkeit prüfen

Brief Report: Anti–RNPC‐3 Antibodies As a Marker of Cancer‐Associated Scleroderma

Arthritis & rheumatology (Hoboken, N.J.), 2017-06, Vol.69 (6), p.1306-1312

2017

Link zum Volltext

Verfügbarkeit prüfen

Cancer in Systemic Sclerosis: Analysis of Antibodies Against Components of the Th/To Complex

Arthritis & rheumatology (Hoboken, N.J.), 2021-02, Vol.73 (2), p.315-323

2021

Link zum Volltext

Verfügbarkeit prüfen

Impact of lung function decline on time to hospitalisation events in systemic sclerosis-associated interstitial lung disease (SSc-ILD): a joint model analysis

Arthritis research & therapy, 2022-01, Vol.24 (1), p.19-19, Article 19

2022

Link zum Volltext

Verfügbarkeit prüfen

Clinical Trials in Systemic Sclerosis: Crossroads and Opportunities

Arthritis & rheumatology (Hoboken, N.J.), 2023-08, Vol.75 (8), p.1328-1330

Hummers, Laura K.

2023

Link zum Volltext

Verfügbarkeit prüfen

Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertension

Circulation. Heart failure, 2013-09, Vol.6 (5), p.953-963

2013

Link zum Volltext

Verfügbarkeit prüfen

Hemodynamic Predictors of Survival in Scleroderma-related Pulmonary Arterial Hypertension

American journal of respiratory and critical care medicine, 2010-07, Vol.182 (2), p.252-260

2010

Link zum Volltext

Verfügbarkeit prüfen

Association of Fibrosing Myopathy in Systemic Sclerosis and Higher Mortality

Arthritis care & research (2010), 2017-11, Vol.69 (11), p.1764-1770

2017

Link zum Volltext

Verfügbarkeit prüfen

Predicting clinical events using Bayesian multivariate linear mixed models with application to scleroderma

BMC medical research methodology, 2021-11, Vol.21 (1), p.1-249, Article 249

2021

Link zum Volltext

Verfügbarkeit prüfen

Telangiectases in scleroderma: a potential clinical marker of pulmonary arterial hypertension

Journal of rheumatology, 2010-01, Vol.37 (1), p.98

2010

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of risk factors for pseudo-obstruction in systemic sclerosis

Seminars in arthritis and rheumatism, 2019-12, Vol.49 (3), p.405-410

2019

Link zum Volltext

Verfügbarkeit prüfen

Targeting of dermal myofibroblasts through death receptor 5 arrests fibrosis in mouse models of scleroderma

Nature communications, 2019-03, Vol.10 (1), p.1128-1128, Article 1128

2019

Link zum Volltext

Verfügbarkeit prüfen

Abnormalities in the regulators of angiogenesis in patients with scleroderma

Journal of rheumatology, 2009-03, Vol.36 (3), p.576

2009

Link zum Volltext

Verfügbarkeit prüfen

Long-term experience of mycophenolate mofetil for treatment of diffuse cutaneous systemic sclerosis

Annals of the rheumatic diseases, 2011-06, Vol.70 (6), p.1104-1107

2011

Link zum Volltext

Verfügbarkeit prüfen

Scleroderma-like fibrosing disorders

Rheumatic diseases clinics of North America, 2008-02, Vol.34 (1), p.199

2008

Link zum Volltext

Verfügbarkeit prüfen

Tricuspid annular plane systolic excursion is a robust outcome measure in systemic sclerosis-associated pulmonary arterial hypertension

Journal of rheumatology, 2011-11, Vol.38 (11), p.2410

2011

Link zum Volltext

Verfügbarkeit prüfen

Late-age onset systemic sclerosis

Journal of rheumatology, 2011-07, Vol.38 (7), p.1317

2011

Link zum Volltext

Verfügbarkeit prüfen

Thrombotic complications after radial arterial line placement in systemic sclerosis: A case series

Seminars in arthritis and rheumatism, 2016-10, Vol.46 (2), p.196-199

2016

Link zum Volltext

Verfügbarkeit prüfen

Symptomatic and Electrodiagnostic Features of Peripheral Neuropathy in Scleroderma

Arthritis care & research (2010), 2016-08, Vol.68 (8), p.1150-1157

2016

Link zum Volltext

Verfügbarkeit prüfen

Oxalate nephropathy in systemic sclerosis: Case series and review of the literature

Seminars in arthritis and rheumatism, 2015-12, Vol.45 (3), p.315-320

2015

Link zum Volltext

Verfügbarkeit prüfen

Scleromyxedema

Current opinion in rheumatology, 2014-11, Vol.26 (6), p.658-662

Hummers, Laura K

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 146

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(134)
Mit Volltextzugriff
(124)

Publikationsform

Sprache

Englisch
(146)
Japanisch
(28)

Erscheinungsjahr

n.n

Thema

Science & Technology
(109)
Life Sciences & Biomedicine
(108)
Humans
(88)
Rheumatology
(87)
Female
(63)
Male
(57)
Middle Aged
(57)
Scleroderma
(54)
Adult
(47)
Systemic Sclerosis
(47)
Scleroderma, Systemic - Complications
(43)
Aged
(39)
Pulmonary Hypertension
(19)
Biological And Medical Sciences
(18)
Medical Sciences
(18)
Risk Factors
(18)
Hypertension, Pulmonary - Etiology
(17)
Patients
(17)
Scleroderma, Systemic - Diagnosis
(17)
Scleroderma, Systemic - Physiopathology
(15)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Symptoms of Autonomic Dysfunction in Systemic Sclerosis Assessed by the COMPASS-31 Questionnaire

Gastrointestinal involvement in systemic sclerosis: diagnosis and management

Right Ventricular Functional Reserve in Pulmonary Arterial Hypertension

Brief Report: Anti–RNPC‐3 Antibodies As a Marker of Cancer‐Associated Scleroderma

Cancer in Systemic Sclerosis: Analysis of Antibodies Against Components of the Th/To Complex

Impact of lung function decline on time to hospitalisation events in systemic sclerosis-associated interstitial lung disease (SSc-ILD): a joint model analysis

Survival and Predictors of Mortality in Systemic Sclerosis‐Associated Pulmonary Arterial Hypertension: Outcomes From the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry

Clinical Trials in Systemic Sclerosis: Crossroads and Opportunities

Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertension

Hemodynamic Predictors of Survival in Scleroderma-related Pulmonary Arterial Hypertension

Association of Fibrosing Myopathy in Systemic Sclerosis and Higher Mortality

Predicting clinical events using Bayesian multivariate linear mixed models with application to scleroderma

Telangiectases in scleroderma: a potential clinical marker of pulmonary arterial hypertension

Evaluation of risk factors for pseudo-obstruction in systemic sclerosis

Targeting of dermal myofibroblasts through death receptor 5 arrests fibrosis in mouse models of scleroderma

Abnormalities in the regulators of angiogenesis in patients with scleroderma

Long-term experience of mycophenolate mofetil for treatment of diffuse cutaneous systemic sclerosis

Scleroderma-like fibrosing disorders

Tricuspid annular plane systolic excursion is a robust outcome measure in systemic sclerosis-associated pulmonary arterial hypertension

Late-age onset systemic sclerosis

Thrombotic complications after radial arterial line placement in systemic sclerosis: A case series

Symptomatic and Electrodiagnostic Features of Peripheral Neuropathy in Scleroderma

Development of pulmonary hypertension in a high-risk population with systemic sclerosis in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) cohort study

Oxalate nephropathy in systemic sclerosis: Case series and review of the literature

Scleromyxedema

Suchergebnisse filtern